Wednesday, 7 October 2015

Britney buys WX 43.57: WuXi does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Securities and Exchange Commission, as well as the Schedule 13E-3 transaction statement and the proxy statement to be filed by the Company in connection with the Merger. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. This announcement is neither a solicitation of proxy, an offer to purchase nor a solicitation of an offer to sell any securities and it is not a substitute for any proxy statement or other filings that may be made with the SEC should the Merger proceed. These documents will be filed with or furnished to the SEC. In addition, certain participants in the Merger will prepare and mail to the Company's shareholders a Schedule 13E-3 transaction statement that will include the proxy statement.


Kandy:
Fangda Partners is serving as PRC legal counsel to the Buyer Group.

Ginny:
Weil, Gotshal & Manges LLP is serving as U.S. and Hong Kong legal counsel to Boyu Capital and the Buyer Group.

Georgann:
Sullivan & Cromwell is serving as U.S. and Hong Kong legal counsel to Ally Bridge and the Buyer Group.

Eugenia:
Wilson Sonsini Goodrich & Rosati, P.C. is serving as U.S. and Hong Kong legal counsel to the Founders and the Buyer Group.

Clotilde:
Bank of America Merrill Lynch is serving as the financial advisor to the Buyer Group.

Amina:
O'Melveny & Myers LLP is serving as U.S. legal counsel to WuXi.

Kelly:
If completed, the Merger will result in the Company becoming a privately-held company and ADSs will no longer be listed on the NYSE.

Andria:
The Merger, which is currently expected to close during the fourth quarter of 2015, is subject to shareholder approval as well as certain other customary closing conditions.

Lue:
Ge Li, the chairman and chief executive officer, Mr.

Allyson:
Take the quiz and test your knowledge on both.

Wuxi Pharmatech [Cayman] Inc. (NYSE:WX)
//stockhand.net/us/?q=nyse%3Awx&id=231727

No comments:

Post a Comment